Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
Despite the success of antiretroviral therapy (ART) at suppressing HIV-1 infection, a cure that eradicates all HIV-1-infected cells has been elusive. The latent viral reservoir remains intact in tissue compartments that are not readily targeted by the host immune response that could accelerate the r...
Main Author: | Matthew R. Gardner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00176/full |
Similar Items
-
Current methods for detecting and assessing HIV-1 antibody resistance
by: Stanley Odidika, et al.
Published: (2025-01-01) -
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
by: Yubin Liu, et al.
Published: (2020-01-01) -
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
by: Jianliang Xu, et al.
Published: (2024-07-01) -
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01) -
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
by: Philippe Colin, et al.
Published: (2023-05-01)